Trending stocks today
Akoya Biosciences (AKYA-Q)
NASDAQ:AKYA
2.45
0.01
(0.41%) 1d
Financials
Technical Analysis
This summary was created by AI, based on 1 opinions in the last 12 months.
Experts have a mixed view of Akoya Biosciences (AKYA-Q) stock. One expert believes that the company is losing money and is too speculative. This negative sentiment may be a cause for concern for potential investors. However, it's important to note that the stock market is unpredictable, and opinions from different experts may vary. As such, it's crucial for investors to conduct thorough research and consider various factors before making investment decisions.
N/A
Unknown
- «
- ‹
- 1
- ›
- »
Akoya Biosciences(AKYA-Q) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 1
Akoya Biosciences(AKYA-Q) Frequently Asked Questions
What is Akoya Biosciences stock symbol?
Akoya Biosciences is a American stock, trading under the symbol AKYA-Q on the NASDAQ (AKYA). It is usually referred to as NASDAQ:AKYA or AKYA-Q
Is Akoya Biosciences a buy or a sell?
In the last year, 1 stock analyst published opinions about AKYA-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Akoya Biosciences.
Is Akoya Biosciences a good investment or a top pick?
Akoya Biosciences was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Akoya Biosciences.
Why is Akoya Biosciences stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Akoya Biosciences worth watching?
In the last year 1 stock analyst on Stockchase covered Akoya Biosciences. The stock is worth watching.
What is Akoya Biosciences stock price?
On 2024-07-26, Akoya Biosciences (AKYA-Q) stock closed at a price of $2.45.
It's losing money and too speculative.